Imagion Biosystems Limited has released “Form 604: Notice of change of interests of substantial holder” to the market.
Read Form 604.
Quarterly Activity Report – Quarter ending 31 December 2023
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal